Median overall survival by cardiac staging system
| Staging system . | Median overall survival . |
|---|---|
| Mayo 20043,* | |
| I | 26.4 mo |
| II | 10.5 mo |
| III | 3.5 mo |
| Boston University1,† | |
| I | Not reached |
| II | 9.4 y |
| III | 4.3 y |
| Staging system . | Median overall survival . |
|---|---|
| Mayo 20043,* | |
| I | 26.4 mo |
| II | 10.5 mo |
| III | 3.5 mo |
| Boston University1,† | |
| I | Not reached |
| II | 9.4 y |
| III | 4.3 y |
Stage I (TnI <0.1 ng/mL and NT-proBNP <332 pg/mL), stage II (TnI >0.1 ng/mL and NT-proBNP >332 pg/mL), and stage III (TnI >0.1 ng/mL and NT-proBNP >332 pg/mL).
Stage I (TnI <0.1 ng/mL and BNP <81 pg/mL), stage II (TnI >0.1 ng/mL or NT-proBNP >81 pg/mL), and stage III (TnI >0.1 ng/mL and NT-proBNP >81 pg/mL).